| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +15% |
| 3Y CAGR | -3% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +17% |
| 3Y CAGR | +208% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹23,320.00 +113.00 (0.49%) | 29,793.76 | 59.85 | 15.9 | ||
PfizerPFIZER | ₹4,874.80 -115.60 (2.32%) | 22,802.96 | 31.02 | 5.43 | ||
Granules IndiaGRANULES | ₹858.40 +0.85 (0.10%) | 21,247.35 | 32.08 | 4.5 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,753.00 -39.50 (0.51%) | 19,479.00 | 114.84 | 22.32 |